CN Patent

CN110831602A — 奥贝胆酸的结晶形式

Assigned to Intercept Pharmaceuticals Inc · Expires 2020-02-21 · 6y expired

What this patent protects

描述了奥贝胆酸的结晶形式及其制备方法和用途。

USPTO Abstract

描述了奥贝胆酸的结晶形式及其制备方法和用途。

Drugs covered by this patent

Ocaliva (OBETICHOLIC ACID) · Intercept Pharms Inc

Patent Metadata

Patent number: CN110831602A
Jurisdiction: CN
Classification: —
Expires: 2020-02-21
Drug substance claim: No
Drug product claim: No
Assignee: Intercept Pharmaceuticals Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.